Literature DB >> 31429019

Circumferential Shaving of the Cavity in Breast-Conserving Surgery: A Randomized Controlled Trial.

Kai Chen1,2, Liling Zhu1,2, Lili Chen1,2, Qian Li1,2, Shunrong Li3,4, Na Qiu1,2, Yaping Yang1,2, Fengxi Su1,2, Erwei Song5,6,7.   

Abstract

BACKGROUND: This randomized controlled trial aimed to investigate the effects of circumferential shaving on reducing the intraoperative margin positivity rate (MPR) during breast-conserving surgery (BCS).
METHODS: Eligible breast cancer patients were randomly assigned into no-shave and shave groups. In the no-shave group, the cavity margins were collected for assessment after the tumor resection, whereas in the shave group, a circumferential shaving was performed before collecting the cavity margins. The primary outcome was the intraoperative MPR by frozen section analysis.
RESULTS: A total of 181 patients, with a median age of 49 years, were randomized. Patient characteristics at baseline were well-balanced between the two groups. The intraoperative MPRs (12.1% vs. 7.8%, p = 0.38), postoperative MPRs (16.5% vs. 7.8%, p = 0.073), intraoperative re-excision rates (26.4% vs. 23.3%, p = 0.64), second operation rates (4.4% vs. 1.1%, p = 0.34), and successful BCS rate (93.4% vs. 94.4%, p = 0.94) were all similar between the no-shave and the shave groups. The volume of the shaved tissues was significantly increased in patients with larger breast volume (p < 0.01). In patients with C-E cup breasts, the no-shave and shave groups had 16.7% and 0% (p = 0.03) intraoperative MPRs, and 22.0% and 0% (p = 0.01) postoperative MPRs, respectively. In patients with A-B cup breasts, the MPRs were similar between the two groups. The presence of the ductal carcinoma in situ component is the only determinant of margin positivity.
CONCLUSIONS: Circumferential shaving did not significantly reduce the MPR in BCS. Its benefit depends on the volume of the shaved tissues and the breast. Trial registration This trial was registered at ClinicalTrials.gov (NCT02648802).

Entities:  

Mesh:

Year:  2019        PMID: 31429019     DOI: 10.1245/s10434-019-07725-w

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

1.  Prognostic factors for residual occult disease in shave margins during partial mastectomy.

Authors:  Julie B Siegel; Rupak Mukherjee; Yeonhee Park; Abbie R Cluver; Catherine Chung; David J Cole; Mark A Lockett; Nancy Klauber-DeMore; Andrea M Abbott
Journal:  Breast Cancer Res Treat       Date:  2021-06-16       Impact factor: 4.872

2.  Does cavity margin shaving reduce residual tumor and re-excision rates? A systematic review.

Authors:  M Fernandez-Pacheco; O Ortmann; A Ignatov; E C Inwald
Journal:  Arch Gynecol Obstet       Date:  2022-05-20       Impact factor: 2.344

3.  A single-center, self-controlled, phase I clinical trial of mitoxantrone hydrochloride injection for lymph tracing for sentinel lymph node identification of breast cancer.

Authors:  Benlong Yang; Shuyue Zheng; Xiaoyan Huang; Jiajian Chen; Zhebin Liu; Guangyu Liu; Shujun Wang; Zhimin Shao; Jiong Wu
Journal:  Gland Surg       Date:  2021-03

4.  Letter to the Editor: The Impact of Neoadjuvant Chemotherapy on Margin Re-excision in Breast-Conserving Surgery.

Authors:  Dileep Ramesh Hoysal; Gaurav Agarwal
Journal:  World J Surg       Date:  2021-02-26       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.